R. Breslow

Molecular Biology · 2001–2007

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom R. Breslow trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. PA Marks

Who trusts R. Breslow overall

  1. PA Marks

Papers from R. Breslow's perspective

Ordered by how strongly the researchers R. Breslow trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Histone deacetylases and cancer: causes and therapies (Nature Reviews. Cancer)
  2. The language of covalent histone modifications (Nature)
  3. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. (Proceedings of the National Academy of Sciences of the United States of America)
  4. Clinical development of histone deacetylase inhibitors as anticancer agents. (Annual Review of Pharmacology and Toxicology)
  5. Acetylation: a regulatory modification to rival phosphorylation? (EMBO Journal)
  6. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. (Biochemical and Biophysical Research Communications - BBRC)
  7. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes (Nature Medicine)
  8. Mutations truncating the EP300 acetylase in human cancers (Nature Genetics)
  9. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors (Proceedings of the National Academy of Sciences of the United States of America)
  10. Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. (Journal of Clinical Oncology)

Their papers